GeneSight – Pharmacogenomic Testing
Dr. Holly Johnson, Director of Medical Information at Myriad Mental Health discusses the GeneSight test that analyzes genes to see how a person may respond to commonly prescribed mental health medications. She also talks about a recent survey looking at the relationship between primary care physicians and their patients when it comes to mental health issues.
Holly Johnson is the Director of Medical Information at Myriad Mental Health. Her focus is on medical strategy, evidence generation, medical content development, and healthcare provider consultations and interactions. She leads her team to provide quality education to healthcare providers, patients, and internal stakeholders. Dr. Johnson received her Ph.D. in Neuroscience from Mayo Clinic and then did postdoctoral research at St. Jude Children’s Research Hospital. Her research has primarily focused on mechanisms of blood-brain barrier disruption in neurological disease.
0 Comments